Skin Cancer Vitals for September 2017

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

We screened more than 305 studies on Skin Cancer during the last 4 weeks. These are the most important.

Melanoma: pembrolizumab outperforms ipilimumab in phase 3 study ...